<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03407755</url>
  </required_header>
  <id_info>
    <org_study_id>H-17006354</org_study_id>
    <nct_id>NCT03407755</nct_id>
  </id_info>
  <brief_title>Air Versus SF6 for Descemet's Membrane Endothelial Keratoplasty (DMEK)</brief_title>
  <official_title>Air Versus SF6 for Descemet's Membrane Endothelial Keratoplasty (DMEK)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Glostrup University Hospital, Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Glostrup University Hospital, Copenhagen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This blinded, randomized study compares the use of air and sulfur hexaflouride (SF6)
      tamponade in Descemet Membrane Endothelial Keratoplasty.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 15, 2017</start_date>
  <completion_date type="Anticipated">May 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients randomized to either air or sulfur hexafluoride (SF6)</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Surgeon and patient masked to choice of intraocular gas. Study coordinator not masked.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Graft detachment</measure>
    <time_frame>Occurence within 3 months postoperative</time_frame>
    <description>Significant graft detachment: 1/3 of graft and affecting visual function. Measured by OCT.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual acuity</measure>
    <time_frame>3 months postoperative</time_frame>
    <description>Snellen chart (logMAR)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gas fill</measure>
    <time_frame>Serial measurements during postoperative week 1.</time_frame>
    <description>Postoperative gas fill measured by OCT.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Positioning</measure>
    <time_frame>72 hours postoperative</time_frame>
    <description>Pitch and roll of head using positioning device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>Occurence within 3 months postoperative</time_frame>
    <description>Any adverse outcome affecting the eye</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">104</enrollment>
  <condition>Fuchs' Endothelial Dystrophy</condition>
  <condition>Bullous Keratopathy</condition>
  <arm_group>
    <arm_group_label>Air</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intraocular 100% atmospheric air (anterior chamber).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SF6</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intraocular 20% sulphur hexaflouride (anterior chamber).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intraocular gas</intervention_name>
    <description>Participants randomized to either air or SF6 gas in the anterior chamber.</description>
    <arm_group_label>Air</arm_group_label>
    <arm_group_label>SF6</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Eligible for DMEK surgey

        Exclusion Criteria:

        Related to ocular health

          -  Re-DMEK or prior penetrating keratoplasty

          -  Ocular hypertension resistant to topical medication

          -  Previous vitrectomy

          -  Minimally invasive glaucoma devices

          -  Aphakia

          -  Anterior chamber or iris claw lens

          -  Implantable Collamer Lens (ICL)

          -  Clinically significant corneal scarring

          -  Central corneal thickness &gt;750 Âµm

          -  BCVA &lt; 0.1

        Related to general health

          -  Not able to give informed consent

          -  Inability to position correctly due to organic or psychological condition.

        Related to surgical procedure

          -  Graft diameter &gt;9 mm or &lt; 7mm

          -  Graft central endothelial cell count &lt; 2000 cells/mm2

          -  Graft unfolding duration &gt;1 hour

          -  Graft morphology grade 4-5

          -  Significant graft decentration (graft contour not visible in microscope)

          -  Significant presence of Descemet remnants in the graft-host interface

          -  Presence of inward folds

          -  Graft 'stroma-surface' placed facing away from recipient stroma
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark Alberti, MD</last_name>
    <role>Study Director</role>
    <affiliation>Rigshospitalet - Glostrup</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mark Alberti, MD</last_name>
    <phone>+4538634823</phone>
    <email>malb0038@regionh.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Glostrup Hospital, University of Copenhagen</name>
      <address>
        <city>Glostrup</city>
        <zip>2600</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Alberti</last_name>
      <email>mark.jensen.alberti@regionh.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 15, 2018</study_first_submitted>
  <study_first_submitted_qc>January 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 23, 2018</study_first_posted>
  <last_update_submitted>January 29, 2018</last_update_submitted>
  <last_update_submitted_qc>January 29, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 31, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Glostrup University Hospital, Copenhagen</investigator_affiliation>
    <investigator_full_name>Mark Alberti</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Intraocular gas</keyword>
  <keyword>Positioning</keyword>
  <keyword>DMEK</keyword>
  <keyword>Endothelial keratoplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fuchs' Endothelial Dystrophy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>If permitted by the Danish Data Protection Agency</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

